Infiltrating Urothelial Carcinoma
1 clinical trials · Condition
◉ Watch Infiltrating Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations (NCT02818725) | UNICANCER | 2010-06-01 |
Track Infiltrating Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.